Concentrix Corporation $CNXC Shares Sold by SummitTX Capital L.P.

SummitTX Capital L.P. lowered its position in Concentrix Corporation (NASDAQ:CNXC) by 70.8% in the first quarter, Holdings Channel reports. The fund owned 13,373 shares of the company’s stock after selling 32,407 shares during the period. SummitTX Capital L.P.’s holdings in Concentrix were worth $366,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CNXC. Geneos Wealth Management Inc. raised its holdings in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares in the last quarter. Larson Financial Group LLC raised its stake in Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after buying an additional 795 shares during the last quarter. Rothschild Investment LLC lifted its holdings in Concentrix by 52.0% during the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock worth $48,000 after buying an additional 392 shares during the last quarter. Finally, AlphaCore Capital LLC boosted its position in shares of Concentrix by 1,962.1% during the 4th quarter. AlphaCore Capital LLC now owns 1,196 shares of the company’s stock worth $50,000 after acquiring an additional 1,138 shares in the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.

Concentrix Stock Down 1.2%

Concentrix stock opened at $24.60 on Friday. The stock has a 50 day moving average of $25.06 and a two-hundred day moving average of $29.20. Concentrix Corporation has a twelve month low of $19.12 and a twelve month high of $57.88. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -1.15, a PEG ratio of 0.46 and a beta of 0.47. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.01). The company had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.Concentrix’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, research analysts expect that Concentrix Corporation will post 9.67 earnings per share for the current year.

Concentrix Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s payout ratio is currently -6.75%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CNXC shares. Barrington Research cut their target price on Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Robert W. Baird cut their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Canaccord Genuity Group lowered their target price on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research note on Friday, July 24th. Finally, Zacks Research cut shares of Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $32.75.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.